Aidspan: Global Fund Board selects Peter Sands to be the next executive director
“Peter Sands will be the next executive director of the Global Fund. The decision was made by the Board on 14 November at its 38th meeting in Geneva, Switzerland. The decision comes five years less a day after Mark Dybul was selected to be the executive director in 2012. Dybul’s term ended on 31 May 2017. Since then, Marijke Wijnroks has been serving as interim executive director…” (Garmaise, 11/14).

Devex: Exclusive: New Global Fund chief Sands eyes disease elimination as goal
“Peter Sands, the new executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, wants his organization to be more technologically savvy, learn more from its past experiences, and learn from them quickly. That’s how he believes the Global Fund will build on its previous work tackling its targeted diseases and, in the foreseeable future, eliminating them…” (Ravelo, 11/15).

Financial Times: Former StanChart chief to run Global Fund for health
“…The appointment of the former senior banker comes at a sensitive time for international aid, with the U.S., the U.K., and other donor countries reconsidering their support against a backdrop of tightening budgets and competing pressures on development assistance. Mr. Sands told the Financial Times his priorities would include enhancing value for money…” (Jack, 11/14).

Intellectual Property Watch: Global Fund Chooses Former U.K. Banker Peter Sands As New Director
“…Sands, who previously served as chief executive of Standard Chartered Bank, and is chairman of the World Bank’s International Working Group on Financing Pandemic Preparedness, is also a research fellow at the Harvard Global Health Institute and the Harvard Kennedy School of Government…” (New, 11/14).

New York Times: Peter Sands Named Head of Global Disease-Fighting Agency
“…In a brief telephone interview, Mr. Sands said he viewed the job as an ‘enormously exciting opportunity’ and that he hoped to eventually have ‘elimination of the three diseases as epidemics by 2030 firmly in sight’ during his term, which ends in 2022. At the same time, he said, ‘I’m not going to pretend that getting people to write large checks is going to be easy’…” (McNeil, 11/14).